East Asia's Cell & Gene Therapy Landscape: Latest Advancements and Pipelines

Cell and Gene Therapy (CGT) is transforming the treatment landscape for cancer, rare diseases, and degenerative conditions. East Asia comprising of China, Japan, South Korea, and Taiwan has emerged as a global innovation hub, driven by:
- Supportive regulatory frameworks
- World-class clinical research
- Growing Manufacturing capacity
- Strong public–private investments
Download the e-Book HERE
Other
e-Books
Explore other news and updates in the biopharmaceutical industry.
Subscribe For News Updates
Subscribe to the IMAPAC Newsletter to stay informed of the latest news in the biopharmaceutical industry.